China-based Contract Research Organization (CRO) Tigermed (SHE: 300347, HKG: 3347) has announced the completion of its acquisition of Croatia-based Marti Farm. The deal, which strengthens Tigermed’s operational presence in Europe, adds local-level expertise to its global portfolio. Financial details of the transaction were not disclosed.
Marti Farm: Services and Capabilities
Based in Zagreb, Marti Farm is a leading CRO that offers a comprehensive suite of services, including pharmacovigilance, clinical operations, regulatory affairs, medical affairs, and pharmacovigilance software. Established 12 years ago, the firm is particularly renowned for its regulatory consulting services, serving clients across pharmaceuticals, biotechnology, medical devices, and food supplements. Marti Farm also operates a cloud-based pharmacovigilance platform utilized by over 100 companies, enhancing its position as a key player in the industry.
Impact of the Acquisition
The acquisition of Marti Farm marks a strategic move by Tigermed to expand its European footprint and integrate local expertise into its global operations. This partnership is expected to bolster Tigermed’s capabilities in regulatory affairs and pharmacovigilance, positioning it to better serve clients in Europe and beyond.-Fineline Info & Tech
